What is the current Price Target for the Reneo Pharmaceuticals Inc stock?

The average Reneo Pharmaceuticals Inc target price is $35.33. This is 1,841.39% higher than the current stock price. The highest price target is 2,097.80%, the lowest is 1,603.30%. 3 Analysts have issued a price target Reneo Pharmaceuticals Inc 2025 .

How high will the Reneo Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Reneo Pharmaceuticals Inc stock will rise. The performance of stocks, including the Reneo Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Reneo Pharmaceuticals Inc stock today?

The performance of Reneo Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Reneo Pharmaceuticals Inc stock fall?

The decline in Reneo Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Reneo Pharmaceuticals Inc Forecast, price target & analysts

$1.82

0.00%

Nasdaq, Thu, Oct 17 2024

ISIN

US75974E1038

Symbol

RPHM

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Reneo Pharmaceuticals Inc Target price 2024 - Analyst rating & recommendation

Reneo Pharmaceuticals Inc Classifications & Recommendation:

Buy

100%

Reneo Pharmaceuticals Inc Price Target

Target Price	$35.33
Price	$1.82
Potential	1,841.39% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Reneo Pharmaceuticals Inc 2025 . The average Reneo Pharmaceuticals Inc target price is $35.33. This is 1,841.39% register free of charge higher than the current stock price. The highest price target is $40.00 2,097.80% register free of charge , the lowest is $31.00 1,603.30% register free of charge .
	A rating was issued by 3 analysts: 3 Analysts recommend Reneo Pharmaceuticals Inc to buy, 0 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Reneo Pharmaceuticals Inc stock has an average upside potential 2025 of 1,841.39% register free of charge . Most analysts recommend the Reneo Pharmaceuticals Inc stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '23	2024 Estimates
Earnings Per Share $	-25.23	-1.01
	1,090.09%	96.00%
P/E		negative

The average Reneo Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

2023	$-25.23	1,090.09%
2024	$-1.01 96.00% Unlock
2025	$-3.80 276.24% Unlock

Current	-10.80	294.16%
2024	-1.56 85.56% Unlock

Reneo Pharmaceuticals Inc...

Discover more stocks with a high price target

Valneva 259.22%

CureVac N.V. 175.41%

Moderna 119.67%

Plug Power Inc. 90.51%

Bavarian Nordic 87.82%

BioNTech SE - ADR 36.41%

RWE 35.54%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now